Drugs / rgp120/HIV-1SF2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00001042 | ? → Mar 1996 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rgp120/HIV-1SF2 | “Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE)” NCT00001042 ↗ |
| Known as | BIOCINE | “Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE)” NCT00001042 ↗ |
| Modality | Vaccine | “HIV-1 subunit protein vaccine” NCT00001042 ↗ |